Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27555,108,1.06 [0.70-1.60],0.7931238588878142
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28131,145,1.33 [0.93-1.89],0.112715692950112
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27883,1006,1.03 [0.90-1.18],0.6405940339713414
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Candidiasis,28165,305,1.04 [0.81-1.33],0.7613983701128502
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27376,2783,1.05 [0.97-1.15],0.21263715131534
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27619,2094,1.06 [0.97-1.17],0.2047311666013422
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27953,1006,1.18 [1.03-1.35],0.0169998982263583
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28080,45,2.72 [1.52-4.87],0.0007462184735918
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26887,646,1.17 [0.99-1.39],0.0651719426790327
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26002,623,1.12 [0.95-1.34],0.1848942385348048
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26246,175,1.05 [0.76-1.46],0.7509752750326065
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20975,1217,1.10 [0.97-1.24],0.1462732400879043
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26000,287,1.40 [1.09-1.80],0.0086041645476254
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28116,1169,1.14 [1.01-1.30],0.0384032487683334
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,28227,367,0.91 [0.73-1.14],0.4276919910947274
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27488,611,1.08 [0.91-1.29],0.3914108645330543
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28163,716,1.12 [0.95-1.32],0.1695897654943797
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27094,147,1.32 [0.92-1.87],0.1272145591076513
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28269,32,1.03 [0.48-2.21],0.938546186849626
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28071,624,1.15 [0.97-1.37],0.114616956426364
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28108,73,1.02 [0.62-1.67],0.95099157491673
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28177,177,1.46 [1.06-2.02],0.0212043049244611
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28161,161,1.48 [1.06-2.09],0.0225548015165677
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27210,333,1.12 [0.88-1.43],0.3455119130884599
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27122,245,0.92 [0.70-1.22],0.5717767492686503
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27027,80,1.00 [0.62-1.62],0.9896419420290532
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28242,55,1.24 [0.71-2.17],0.4485259228095506
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28205,133,1.05 [0.72-1.53],0.796080181071029
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral warts,28117,45,1.21 [0.64-2.30],0.551929457355343
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28123,51,0.76 [0.41-1.40],0.3782168360887152
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,27976,318,0.99 [0.77-1.26],0.9064093269482494
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28177,77,0.78 [0.47-1.28],0.322100687213766
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28156,80,1.26 [0.78-2.04],0.350110302939178
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12597,42,0.76 [0.38-1.53],0.4442336827429299
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28075,1211,1.00 [0.88-1.13],0.960726267889422
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of meninges,28258,51,0.90 [0.49-1.66],0.747265159794611
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28232,51,0.82 [0.44-1.51],0.5211152463038135
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28246,95,1.28 [0.82-1.98],0.2729337112376023
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of ovary,15611,100,1.52 [0.98-2.34],0.0586638075547978
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28263,284,1.11 [0.86-1.43],0.4248484001543444
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Caecum,28258,211,0.90 [0.67-1.22],0.4914359628732231
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28201,58,0.89 [0.50-1.56],0.6803213726901185
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Descending colon,28261,180,0.82 [0.59-1.14],0.2377539405210422
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,28225,299,0.79 [0.61-1.02],0.0724009678885738
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28192,558,1.06 [0.88-1.28],0.5306548397913119
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28263,321,0.84 [0.66-1.07],0.1632412284826813
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Carcinoma in situ of breast,13418,90,0.96 [0.60-1.53],0.8682471601505479
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13466,104,0.79 [0.51-1.21],0.2758310588804621
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24414,31,0.32 [0.15-0.72],0.0058480993236011
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24423,40,2.97 [1.71-5.18],0.0001194629593327
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28225,114,0.86 [0.57-1.29],0.4627052757203052
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",28225,112,0.89 [0.59-1.34],0.5712463053078383
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Leiomyoma of uterus,14965,417,0.77 [0.62-0.95],0.0169309775746311
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lung cancer and mesothelioma,21001,178,0.83 [0.59-1.17],0.2896502709824571
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lymphoid leukaemia,24413,30,0.49 [0.22-1.11],0.0866735642914618
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24531,148,0.74 [0.51-1.08],0.1237408791928698
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24472,89,1.30 [0.82-2.08],0.2684969564589859
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13520,84,1.02 [0.63-1.65],0.942461275411244
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24436,53,1.27 [0.70-2.28],0.4307707460838289
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24453,70,1.24 [0.74-2.07],0.423552935433158
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24456,73,1.17 [0.71-1.93],0.5469497038444188
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13492,56,1.42 [0.79-2.55],0.2376252636006801
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24442,59,0.94 [0.54-1.63],0.8153358819532429
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11365,418,0.76 [0.61-0.95],0.0157396551896229
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24475,92,1.14 [0.72-1.80],0.5742992523185564
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24440,57,0.86 [0.48-1.53],0.5992707420786985
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24448,65,0.82 [0.47-1.44],0.4932216003196499
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,28022,214,0.88 [0.65-1.20],0.4304541516063779
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of trunk,28217,96,0.84 [0.53-1.32],0.4411047074294639
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanoma in situ,24398,50,0.72 [0.38-1.38],0.324200024927729
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24444,61,1.60 [0.93-2.76],0.087473662192686
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24503,120,1.36 [0.92-2.02],0.127547194629743
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24503,120,0.75 [0.50-1.12],0.1560124811854608
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24453,70,1.62 [0.97-2.69],0.0645861209645249
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,28081,142,0.75 [0.52-1.09],0.1266124835283784
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25043,660,1.21 [1.02-1.44],0.0290830221018917
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25075,692,1.18 [1.00-1.40],0.0517108026607338
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27990,292,1.20 [0.93-1.55],0.1511561552186003
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26810,60,2.84 [1.81-4.45],5.290592234905097e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27770,72,0.60 [0.36-1.00],0.0509260336865619
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27452,2296,1.05 [0.96-1.15],0.3249858167837886
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27049,24,1.88 [0.82-4.28],0.1333045911001349
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27906,37,0.80 [0.39-1.62],0.5307565208950986
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27815,1065,1.20 [1.05-1.37],0.0059870364095476
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27815,1065,1.20 [1.05-1.37],0.0059870364095476
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26810,60,2.61 [1.59-4.29],0.0001529766435979
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27981,956,1.19 [1.04-1.37],0.013749497091432
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27982,113,1.57 [1.05-2.34],0.0271622676281761
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27752,54,1.16 [0.64-2.09],0.6276156323672715
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27740,42,1.06 [0.55-2.06],0.8658265829021353
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28069,200,1.04 [0.76-1.41],0.8081111607046748
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28187,72,0.52 [0.31-0.87],0.0129047703122145
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28037,168,1.11 [0.79-1.55],0.5391251749891011
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27101,76,1.24 [0.75-2.04],0.3961878639291343
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24294,221,0.99 [0.73-1.32],0.9239901726264872
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26299,130,0.37 [0.25-0.54],5.272124457724167e-07
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26313,144,0.31 [0.21-0.46],3.664548649626506e-09
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24111,38,0.51 [0.25-1.06],0.0728695175529607
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26243,70,0.78 [0.46-1.31],0.345865572482456
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25900,155,1.33 [0.94-1.88],0.1098178464098584
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28119,172,1.11 [0.80-1.54],0.5224013338404819
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27995,48,0.65 [0.34-1.24],0.1893536545000199
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27985,38,0.50 [0.24-1.02],0.0549737106460013
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27850,1677,1.03 [0.93-1.15],0.5516474118134749
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25311,1627,1.03 [0.92-1.15],0.5936934683057127
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24114,41,1.34 [0.68-2.63],0.4019526426277365
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26547,58,1.65 [0.95-2.86],0.0750818109718731
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24262,189,1.26 [0.92-1.73],0.1559157285140317
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24140,67,0.74 [0.42-1.28],0.2805166091539017
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26512,2439,1.07 [0.98-1.17],0.1454819178093143
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24197,124,1.36 [0.92-2.01],0.1259017799403916
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24468,395,1.11 [0.89-1.38],0.370390210714405
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28165,281,1.47 [1.14-1.90],0.0033418738318192
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27999,115,1.68 [1.13-2.50],0.010511993305671
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24171,98,1.03 [0.66-1.62],0.8859106290265107
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24112,39,1.20 [0.60-2.40],0.6135541559943567
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27827,1338,1.20 [1.06-1.35],0.0031963327917927
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24205,132,1.77 [1.23-2.55],0.0021998204173358
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24244,171,2.03 [1.49-2.77],7.881430700217837e-06
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24473,400,1.19 [0.96-1.48],0.1052133663267174
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24135,62,0.78 [0.45-1.36],0.3900367351914677
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27992,108,1.87 [1.25-2.81],0.0023776308604252
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24383,310,1.06 [0.82-1.36],0.6557368842092534
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24374,301,0.98 [0.76-1.27],0.8809247974986167
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25803,58,1.58 [0.91-2.76],0.1044372428590491
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27568,3495,1.04 [0.97-1.12],0.3031129202562427
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26526,37,1.68 [0.83-3.39],0.1469957651821976
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26549,60,1.25 [0.71-2.18],0.4346847974451394
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28081,1968,0.97 [0.88-1.07],0.5534239610521312
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28085,1965,0.97 [0.88-1.07],0.5876568616598633
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26528,39,1.38 [0.70-2.72],0.3467771699845058
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27939,1270,1.01 [0.89-1.14],0.8688995412109911
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24998,925,1.06 [0.91-1.22],0.4545696973637311
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28259,139,1.08 [0.75-1.55],0.6741316267050429
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27982,35,0.97 [0.47-1.99],0.9380073694480924
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26759,90,0.83 [0.52-1.31],0.4188930492649977
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26785,116,0.79 [0.53-1.18],0.2465323380816182
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24210,137,1.62 [1.12-2.35],0.0111569474698302
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26438,125,1.14 [0.78-1.67],0.5023415659524909
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1743,71,1.68 [1.04-2.71],0.0325597963389621
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1853,195,0.91 [0.68-1.22],0.5415766148654872
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26352,39,0.54 [0.26-1.11],0.0941461663294325
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1709,37,3.35 [1.91-5.87],2.374116971347484e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27830,1517,0.81 [0.72-0.90],0.0001452331171708
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28020,73,0.74 [0.44-1.23],0.2391904428177669
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26026,281,1.09 [0.84-1.40],0.5220183871429248
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24497,424,1.29 [1.04-1.59],0.0178860822042406
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28180,181,0.96 [0.70-1.33],0.8211433397558051
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27520,57,0.93 [0.52-1.66],0.8073681496748112
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,26964,809,1.04 [0.89-1.21],0.6323009512169713
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27569,106,1.19 [0.78-1.82],0.4160419249768236
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27491,28,1.69 [0.78-3.69],0.1865039971566151
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27569,106,1.38 [0.91-2.09],0.1247525454021444
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20175,968,1.12 [0.98-1.29],0.100385950984254
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,AV-block,25736,188,1.19 [0.86-1.64],0.288145106733922
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28235,260,1.32 [1.01-1.72],0.0434035347544448
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiac arrest,19323,116,0.87 [0.58-1.31],0.503742802156161
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25681,133,1.26 [0.86-1.85],0.2267373128507762
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25629,81,0.96 [0.58-1.57],0.8655088676505238
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28271,21,2.92 [1.33-6.39],0.0073817421424666
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,26087,539,1.13 [0.94-1.37],0.1948510035865098
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27533,1389,1.00 [0.89-1.12],0.9941650723614976
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26295,6165,0.88 [0.83-0.93],7.155113261207898e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27078,189,1.03 [0.75-1.42],0.8581636114779932
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Endocarditis,25592,44,1.93 [1.04-3.59],0.0376038061320302
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28149,523,1.10 [0.91-1.32],0.3394847890008731
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,26875,5015,0.84 [0.79-0.89],1.71841303042519e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26891,5031,0.84 [0.79-0.90],9.602658582627065e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28098,59,1.37 [0.79-2.38],0.2614430023372561
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21949,89,2.51 [1.67-3.78],9.718246167883974e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21925,65,5.47 [4.12-7.27],8.352991291947603e-32
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,28164,709,1.31 [1.11-1.54],0.0010763991297134
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27728,66,0.76 [0.44-1.28],0.2997454221453659
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27702,1547,0.99 [0.89-1.11],0.8757295778866678
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28036,314,1.11 [0.87-1.42],0.3821221382069056
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25744,196,1.31 [0.96-1.78],0.0854130474103412
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28008,611,1.19 [1.00-1.42],0.0452559406690586
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26653,498,1.23 [1.01-1.49],0.0375113156483686
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28212,118,1.50 [1.02-2.22],0.0407443866480687
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28255,208,1.20 [0.89-1.62],0.222349655728025
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Oesophageal varices,26931,42,0.86 [0.44-1.71],0.6730175142579947
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other aneurysm,27515,52,0.89 [0.49-1.62],0.7023412912253953
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,25793,245,1.13 [0.85-1.50],0.3905381744160987
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27526,63,1.22 [0.71-2.10],0.4642630082232259
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27608,145,1.49 [1.05-2.12],0.0263141123062854
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25676,128,1.43 [0.98-2.10],0.0651309054265048
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other disorders of veins,26963,74,1.07 [0.64-1.76],0.805657984451529
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26937,48,1.28 [0.69-2.38],0.4304430458883035
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27470,37,0.41 [0.20-0.86],0.0186489258436291
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26981,92,1.01 [0.64-1.59],0.982553480440785
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26149,601,1.25 [1.05-1.49],0.0116327509475175
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27502,47,1.59 [0.86-2.94],0.1427923262043307
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27811,348,1.25 [1.00-1.58],0.0544965427858765
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27818,160,1.38 [0.99-1.92],0.0598284152764506
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27672,239,1.11 [0.84-1.47],0.4471633598534555
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19466,259,0.91 [0.69-1.20],0.5255201390992108
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27647,209,1.30 [0.97-1.75],0.0790802173107811
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27150,261,0.99 [0.76-1.30],0.9463902542702084
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28002,344,1.03 [0.81-1.30],0.803759410258623
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28229,339,1.24 [0.98-1.57],0.0669739051777695
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25725,177,0.87 [0.62-1.22],0.4164452350790931
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27814,156,1.35 [0.97-1.89],0.0790034728990483
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27554,121,0.63 [0.42-0.94],0.0234739558377183
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28029,367,1.07 [0.86-1.34],0.5305814422481137
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28002,404,1.09 [0.88-1.35],0.4430820997387227
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27703,56,1.24 [0.70-2.21],0.4656466520352729
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27519,56,1.40 [0.78-2.50],0.2585923736945938
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27868,146,1.34 [0.94-1.92],0.1060055526838152
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27579,182,1.03 [0.75-1.41],0.8691307253810157
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,27218,329,1.15 [0.90-1.46],0.2651006048544507
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27472,49,0.54 [0.29-1.03],0.0613868064091834
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28094,543,1.01 [0.84-1.22],0.881453756787706
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28109,386,0.47 [0.38-0.59],1.0833554017134586e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25204,1460,1.04 [0.93-1.17],0.5125395479119548
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,27504,3760,0.96 [0.90-1.04],0.3275067571291311
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28045,458,0.43 [0.35-0.53],1.962892788243088e-15
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25450,1706,1.02 [0.92-1.14],0.680059597402952
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23835,91,1.01 [0.64-1.59],0.9754066896610768
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,27719,1556,1.07 [0.96-1.20],0.2051079879813181
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25552,1808,0.91 [0.83-1.01],0.0873810502288848
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Vascular dementia,28152,22,1.89 [0.83-4.32],0.1291966327363948
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Alzheimer disease,28271,67,0.64 [0.37-1.10],0.1075192727624459
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Bell's palsy,26577,76,1.24 [0.76-2.03],0.392295306246423
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26987,486,0.91 [0.75-1.11],0.3658721950826502
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral cysts,27904,208,0.99 [0.73-1.34],0.9502710830962244
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28188,236,0.78 [0.59-1.04],0.0877427018846126
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28126,24,0.42 [0.17-1.03],0.0583234296598372
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28256,51,2.35 [1.36-4.04],0.0020629608312221
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27755,59,0.61 [0.35-1.09],0.0955629425378325
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,26668,265,0.71 [0.54-0.93],0.0133651662777689
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27780,1377,1.04 [0.93-1.17],0.494115094905493
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28240,277,0.81 [0.62-1.05],0.1119545735941158
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27744,1683,0.81 [0.73-0.90],0.0001075728244595
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Generalized epilepsy,27893,52,0.86 [0.47-1.58],0.6211859651098797
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,28122,170,0.79 [0.56-1.10],0.1575069463945333
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hydrocephalus,27743,47,1.26 [0.67-2.37],0.4729605454310235
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28250,61,1.63 [0.95-2.79],0.0755741915115139
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26583,82,0.82 [0.50-1.35],0.4398654062643208
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26591,90,1.14 [0.72-1.80],0.5742839585030498
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Memory loss,28116,73,0.74 [0.44-1.24],0.2534001885902339
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,26839,436,1.37 [1.11-1.69],0.0032780951477605
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28179,387,1.43 [1.14-1.78],0.0016866664601287
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Motor neuron disease,20579,99,0.79 [0.50-1.24],0.3070092076519135
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28072,144,1.24 [0.86-1.80],0.2484752070484751
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27656,1155,0.99 [0.87-1.12],0.8285875009560033
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,26822,3156,1.00 [0.92-1.08],0.9092168024973468
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28178,76,0.53 [0.32-0.87],0.0128081849618285
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26894,393,1.05 [0.84-1.30],0.6905215774740125
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28198,239,1.34 [1.02-1.77],0.0370109011486097
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23580,312,0.77 [0.59-0.99],0.0388007940908273
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27758,62,0.74 [0.42-1.30],0.2926672486224217
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27814,118,1.05 [0.71-1.56],0.7976742193571463
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28054,91,1.59 [1.02-2.49],0.0422394340178492
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26595,94,1.23 [0.79-1.91],0.3593090708950948
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other headache syndromes,26464,61,1.02 [0.59-1.76],0.9572632487870584
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,28146,450,0.99 [0.80-1.21],0.9084584237376884
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,26996,593,0.95 [0.79-1.13],0.5494526635454773
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Parkinson's disease,28258,165,0.58 [0.41-0.82],0.0019287036875549
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27761,65,1.18 [0.69-2.03],0.5485633793551052
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Restless leg syndrome,28270,45,1.84 [0.98-3.43],0.0560888746522716
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,28018,514,0.86 [0.71-1.04],0.1222903184446417
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27995,36,1.10 [0.53-2.30],0.7907470628323494
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28255,126,0.68 [0.46-1.00],0.0508096698225262
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26533,32,2.21 [1.05-4.63],0.0356515661858336
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28271,68,0.64 [0.37-1.10],0.1052293140102615
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28139,21,2.04 [0.89-4.65],0.0907911566933365
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27781,43,0.84 [0.43-1.65],0.6113590976658132
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27915,222,0.85 [0.63-1.13],0.2648325271479778
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28179,200,0.86 [0.64-1.16],0.3371085360194168
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27510,38,1.15 [0.57-2.33],0.6974839400074503
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27546,74,1.26 [0.76-2.08],0.3735333419816589
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28179,32,0.86 [0.40-1.83],0.6861577094813336
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28070,65,1.26 [0.75-2.12],0.391204055478931
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1715,43,3.02 [1.77-5.17],5.380919123650574e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2028,87,1.47 [0.95-2.27],0.0826403760136881
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27814,76,1.47 [0.90-2.40],0.121238783813713
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28141,637,1.07 [0.91-1.27],0.4172036739742114
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27958,486,1.08 [0.89-1.32],0.4207210575489747
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27612,140,0.91 [0.63-1.31],0.607140233674987
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28176,483,1.09 [0.90-1.33],0.3794373717355422
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28258,54,1.94 [1.11-3.38],0.0191051402101395
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28104,411,1.03 [0.83-1.28],0.7782776382571206
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28228,223,1.18 [0.89-1.58],0.2450467254973961
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28205,128,0.75 [0.51-1.09],0.1339808101244132
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27490,18,0.97 [0.35-2.71],0.9566920697803568
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27501,29,0.88 [0.39-1.96],0.749212008267927
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27505,33,1.00 [0.47-2.10],0.9912385364814578
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28222,396,1.02 [0.82-1.26],0.8792586259609704
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27929,103,0.98 [0.64-1.50],0.940357729823878
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27718,25,1.35 [0.57-3.23],0.4952943752147507
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28080,75,1.13 [0.69-1.85],0.6244821931733757
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28154,149,1.20 [0.85-1.71],0.3020247190702597
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27858,165,1.18 [0.84-1.66],0.3411511543547832
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28152,75,0.69 [0.42-1.14],0.1497202394560894
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28084,258,0.97 [0.75-1.27],0.8368063667682626
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27858,120,1.24 [0.84-1.82],0.2833874423944459
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27543,1079,0.96 [0.84-1.10],0.5541650523096808
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28128,123,1.18 [0.80-1.74],0.3972900884121948
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28245,115,1.47 [0.99-2.19],0.0545487548607799
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27743,271,1.03 [0.79-1.34],0.8102585932685467
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28043,38,2.21 [1.16-4.22],0.0162260264911213
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28242,38,2.25 [1.21-4.18],0.0103139519510849
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27510,38,1.18 [0.58-2.40],0.641227468326164
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27591,119,1.18 [0.79-1.76],0.4124198301745259
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27575,71,0.94 [0.57-1.56],0.8068937679567929
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27751,58,1.33 [0.75-2.37],0.3293909320436785
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27552,48,0.98 [0.52-1.86],0.960765921994728
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27885,59,1.00 [0.57-1.77],0.9958609260292992
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27922,96,0.97 [0.63-1.50],0.8837490557973222
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27565,93,0.91 [0.59-1.42],0.6873964462053052
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27628,124,0.97 [0.65-1.45],0.8935650775771379
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27541,37,1.45 [0.73-2.88],0.2905529396333484
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27310,846,1.08 [0.94-1.26],0.2769797918824039
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27522,50,0.90 [0.49-1.65],0.7279194211097831
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28051,313,1.10 [0.86-1.41],0.4398123780747929
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27777,39,0.48 [0.24-0.97],0.0394515774044985
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27869,131,1.72 [1.19-2.47],0.0035026670998134
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28071,61,1.39 [0.81-2.39],0.2315625723514348
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28228,101,1.37 [0.89-2.11],0.1563815150139557
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28152,137,1.12 [0.78-1.62],0.5365959691564461
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28065,55,1.05 [0.59-1.89],0.8626187152571015
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28065,55,1.66 [0.93-2.95],0.085274837933959
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28184,537,0.99 [0.82-1.19],0.8828693210831726
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27978,331,0.97 [0.76-1.24],0.8134590292161981
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27745,98,0.80 [0.52-1.24],0.3285856124730525
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27729,82,1.93 [1.23-3.04],0.0045307403018462
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute pharyngitis,27976,84,1.10 [0.69-1.76],0.682073926854764
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28132,240,1.18 [0.90-1.56],0.236231884963628
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27956,64,1.22 [0.72-2.07],0.4645445605195447
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza,26932,80,1.29 [0.80-2.08],0.2982586245004693
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26930,78,1.20 [0.74-1.95],0.458201738665305
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20953,130,0.96 [0.65-1.42],0.8435580384995337
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic rhinitis,28114,320,0.88 [0.69-1.13],0.3281621293494698
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22483,1805,0.95 [0.86-1.06],0.3762791907254392
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22599,1776,0.95 [0.85-1.05],0.3226340833145138
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27978,96,1.08 [0.70-1.67],0.7178602547522744
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26910,58,1.03 [0.59-1.79],0.927568768896882
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bronchiectasis,25161,184,0.77 [0.56-1.06],0.1121227125450342
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25020,43,1.19 [0.61-2.30],0.6127677146097065
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27388,2411,0.88 [0.81-0.97],0.0066895978981832
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26754,68,0.78 [0.46-1.33],0.3579533833673305
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,26860,174,1.04 [0.75-1.46],0.8057535466410692
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28161,733,0.63 [0.53-0.74],1.5087262519860816e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,26816,130,1.18 [0.80-1.75],0.3954426513074802
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26304,4351,0.98 [0.92-1.05],0.6139824023123974
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27071,385,1.09 [0.87-1.36],0.4616145387528019
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,27946,518,0.60 [0.49-0.73],1.998794815118282e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Emphysema,25165,188,0.57 [0.42-0.79],0.0007452403540904
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26996,118,1.12 [0.75-1.68],0.5703377622152572
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28084,1232,0.94 [0.83-1.07],0.3406254639261271
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,27022,144,1.23 [0.86-1.77],0.2576081825654224
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Later onset COPD,26795,215,0.66 [0.48-0.89],0.0067743484224092
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28263,160,1.01 [0.72-1.42],0.9526462813662412
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,26801,115,1.41 [0.94-2.11],0.0970834388856284
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28059,625,0.85 [0.71-1.01],0.0617704049602604
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,28088,1267,0.91 [0.80-1.03],0.1290875318692664
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27596,910,1.02 [0.88-1.18],0.8230864203598365
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other pleural conditions,26853,32,0.52 [0.23-1.15],0.1066422030000983
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28214,205,1.43 [1.07-1.93],0.0172720996089699
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28186,864,0.85 [0.74-0.99],0.0353815199117663
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,27428,607,1.11 [0.93-1.32],0.2646720416784913
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural plaque,26877,56,0.54 [0.30-0.98],0.0422280258470607
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27873,1021,0.88 [0.77-1.01],0.0781082342732445
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28242,139,1.01 [0.70-1.46],0.9518645407561928
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumothorax,26885,64,0.47 [0.27-0.83],0.009049346778366
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pollen allergy,28234,272,0.87 [0.66-1.14],0.302127240976196
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pulmonary oedema,28046,37,2.47 [1.32-4.63],0.0048407371613768
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20861,38,0.31 [0.15-0.64],0.0016156320680121
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28040,606,0.84 [0.70-1.00],0.0474057576908142
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27006,320,0.89 [0.69-1.14],0.3487622579117521
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Viral pneumonia,27047,195,0.87 [0.64-1.19],0.3839540302529846
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27999,167,0.98 [0.70-1.36],0.8999970541759224
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16321,106,1.15 [0.75-1.75],0.5260752929012495
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21616,65,1.63 [0.96-2.75],0.0692877423403923
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,28064,162,0.95 [0.67-1.36],0.7878988734471679
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute gastritis,22589,77,1.20 [0.73-1.97],0.4825912076264865
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,26638,169,0.82 [0.58-1.15],0.2489383241524143
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute peritonitis,27819,76,2.17 [1.37-3.45],0.0009923667015886
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27470,87,0.58 [0.36-0.92],0.0223316832391684
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Barrett oesophagus,22872,360,1.13 [0.89-1.42],0.3147475726511837
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26526,57,0.93 [0.52-1.64],0.7942670859224135
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27853,57,0.93 [0.52-1.64],0.7932255178893015
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,26657,188,0.98 [0.71-1.35],0.8923166176854948
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,27399,930,1.10 [0.95-1.27],0.18539080755219
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,22775,263,1.24 [0.95-1.62],0.1168535236594889
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26513,44,1.23 [0.65-2.33],0.5323947581424364
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28120,81,1.18 [0.74-1.89],0.4888668652716165
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,26801,121,0.86 [0.57-1.29],0.4685284606782333
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Collagenous colitis,26661,63,0.80 [0.46-1.40],0.4419350846737245
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28079,214,1.00 [0.74-1.35],0.9875561138318308
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,28044,1203,1.04 [0.92-1.18],0.5415965014617435
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,26697,99,1.32 [0.85-2.05],0.2184767509623126
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27918,71,1.39 [0.83-2.32],0.2137263407599338
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26694,96,1.65 [1.06-2.57],0.0256863777028646
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,27406,273,0.94 [0.72-1.22],0.6176738939356508
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26166,1881,1.03 [0.93-1.14],0.5485890162822137
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,28107,205,0.85 [0.62-1.16],0.2964324105571375
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,28149,766,0.93 [0.79-1.09],0.3458225056242328
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26531,4019,1.06 [0.99-1.14],0.0863118580170834
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27771,638,0.97 [0.81-1.15],0.6961183209582876
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28190,447,1.30 [1.06-1.59],0.0128555826563438
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27269,136,0.99 [0.68-1.43],0.9372033740128264
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27100,73,0.98 [0.59-1.62],0.9290689337405372
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27987,1307,0.99 [0.88-1.12],0.8707306637229537
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of tongue,27113,124,1.52 [1.03-2.25],0.0349336009284455
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27744,1275,1.06 [0.93-1.19],0.3832957778629853
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24056,2505,1.00 [0.92-1.09],0.988423212298713
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,22658,146,0.97 [0.67-1.39],0.8649941900130281
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28200,116,0.81 [0.54-1.21],0.3012317005533756
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28130,81,0.88 [0.54-1.44],0.6154643462355821
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27487,104,1.09 [0.72-1.65],0.6912093993709261
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21737,186,0.99 [0.72-1.37],0.9464266266157808
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,23039,527,0.91 [0.75-1.10],0.3421305821234506
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,22797,285,1.08 [0.83-1.40],0.5612321939087294
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24827,2315,1.05 [0.96-1.15],0.2942942892887383
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22923,411,0.99 [0.80-1.23],0.9133100315421544
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23085,8299,1.02 [0.98-1.08],0.3207273767070672
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,27734,1054,0.98 [0.86-1.12],0.7468492831867442
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27197,64,1.15 [0.67-1.98],0.6093056812187652
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22511,1333,1.04 [0.92-1.17],0.5682686613682422
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27439,56,0.90 [0.50-1.60],0.7198968365822609
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,27091,2806,1.00 [0.92-1.09],0.9136945429766288
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,28140,75,0.82 [0.49-1.38],0.4579541261416388
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impaction of intestines,21584,33,2.07 [0.98-4.37],0.0556327725769697
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,24972,687,0.95 [0.80-1.12],0.5354253530877715
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24364,79,1.35 [0.82-2.21],0.235889073512628
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21628,77,0.68 [0.41-1.13],0.1411299730634778
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26822,142,0.93 [0.64-1.35],0.688730960477512
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22139,588,1.07 [0.89-1.29],0.4560959894547145
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28244,399,0.99 [0.79-1.22],0.8936139701367852
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27321,723,1.18 [1.00-1.39],0.0452160412907804
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27515,917,1.13 [0.97-1.30],0.1079494312793575
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22667,155,1.41 [1.00-2.00],0.049390896215054
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,23016,504,1.18 [0.97-1.43],0.1003029877686186
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28227,139,0.81 [0.56-1.18],0.2813289863948343
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24333,48,1.59 [0.86-2.93],0.1362219656849273
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22885,1334,1.08 [0.96-1.22],0.1887699183022591
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26670,201,1.08 [0.79-1.46],0.6421514995658433
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26634,165,1.02 [0.72-1.44],0.9055910903840504
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,23097,1546,0.95 [0.85-1.06],0.3442710462283395
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,26576,5025,1.02 [0.96-1.09],0.5123317432352309
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27109,205,0.79 [0.58-1.08],0.1417840251188877
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,28001,618,1.01 [0.84-1.20],0.9515086463821514
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23068,556,1.05 [0.87-1.27],0.5910780820096933
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26557,88,1.17 [0.74-1.86],0.5011600233074709
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28131,388,1.18 [0.95-1.47],0.1340351347991213
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23319,807,1.14 [0.98-1.33],0.0902896359323686
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27748,1068,0.98 [0.86-1.12],0.817919203246743
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27329,196,0.87 [0.64-1.19],0.3885245157098221
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22802,1251,1.01 [0.89-1.14],0.8580840468924661
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24345,1833,1.22 [1.10-1.35],0.0001131549925065
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27468,85,0.82 [0.51-1.32],0.4060767443404806
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27398,800,1.18 [1.01-1.38],0.0318139549601537
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21787,236,0.94 [0.70-1.25],0.6561092077019323
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28115,97,1.03 [0.66-1.62],0.8915394658355764
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21908,357,0.92 [0.73-1.16],0.4682353910378907
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26819,139,1.27 [0.88-1.83],0.1941100688941425
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28262,60,1.46 [0.84-2.55],0.1787786182172555
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27151,132,1.18 [0.81-1.73],0.3956929337774962
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Toxic colitis,26631,33,1.03 [0.49-2.18],0.943486283491362
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22703,191,0.90 [0.65-1.24],0.5220022121476389
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,26746,148,1.09 [0.76-1.56],0.6577799697258605
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26727,129,1.21 [0.82-1.79],0.3295038002515797
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,24568,283,0.72 [0.55-0.93],0.0125470176859561
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21656,105,0.64 [0.42-0.99],0.0456798316003873
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,24514,229,0.97 [0.73-1.30],0.8418816695829642
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Volvulus,21618,67,1.14 [0.67-1.94],0.6325641242170346
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28212,163,1.00 [0.71-1.42],0.9862193044629756
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27992,81,0.84 [0.51-1.36],0.4743588646310188
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26749,152,0.95 [0.66-1.37],0.7891400518272048
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27636,575,1.07 [0.89-1.28],0.4937649371774079
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27262,201,1.10 [0.81-1.49],0.5543232316373248
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26778,181,0.82 [0.59-1.14],0.2334337964715827
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28005,236,1.03 [0.78-1.37],0.8187948169862106
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28174,405,1.02 [0.82-1.26],0.8818091713777751
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27818,49,0.71 [0.38-1.34],0.2948539402367363
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26772,2659,0.98 [0.90-1.07],0.7185262842252274
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27804,454,0.90 [0.73-1.10],0.306894086035527
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27675,325,0.91 [0.72-1.17],0.4668561179684466
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27873,812,1.05 [0.90-1.22],0.5205602925498793
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28257,48,0.67 [0.35-1.27],0.2217239623647411
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26654,57,0.60 [0.34-1.06],0.0806005091920142
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27390,40,0.78 [0.39-1.56],0.4895391861950076
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27998,229,1.02 [0.77-1.36],0.8826639357425979
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26891,294,1.12 [0.86-1.45],0.3983999372517803
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26634,37,1.22 [0.60-2.48],0.5879713756913925
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28186,68,1.24 [0.73-2.09],0.4291553346406681
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27198,137,0.89 [0.61-1.30],0.5613025485146383
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28073,162,0.91 [0.64-1.29],0.5908812954566225
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27802,33,1.88 [0.91-3.87],0.0870163072487863
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26652,55,0.90 [0.50-1.64],0.7399177568465665
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27732,1135,0.96 [0.84-1.09],0.4939171052184511
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26922,325,1.04 [0.81-1.33],0.782477391318672
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26638,41,1.11 [0.56-2.19],0.760953648156154
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28187,276,0.87 [0.66-1.13],0.2882622896399042
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27833,64,1.06 [0.62-1.79],0.8378710266728062
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28138,227,0.88 [0.66-1.18],0.4090935067952309
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28236,187,1.01 [0.73-1.40],0.95769187118324
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26723,126,0.98 [0.66-1.45],0.9052143969126863
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26793,196,0.92 [0.67-1.27],0.6234367668013197
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28226,177,1.01 [0.72-1.41],0.9468574791217462
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26730,133,0.92 [0.64-1.34],0.6767937445195493
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28237,119,1.36 [0.92-2.02],0.1276112417470968
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24821,134,1.06 [0.73-1.56],0.7481315057225393
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26403,4768,1.01 [0.94-1.07],0.8758778322396448
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24994,3359,0.94 [0.87-1.01],0.1001184519453712
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24784,97,1.16 [0.74-1.80],0.5220029300360042
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25374,158,1.04 [0.74-1.48],0.811408217031947
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25382,166,1.10 [0.79-1.54],0.5744947804360894
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28037,116,1.11 [0.75-1.65],0.5935950618557182
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25262,46,0.36 [0.19-0.69],0.0021172955202071
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22398,763,0.89 [0.76-1.05],0.172404607182232
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28210,126,0.86 [0.58-1.27],0.4495497898726135
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25518,302,0.79 [0.61-1.02],0.0680929938332844
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24739,6408,0.98 [0.93-1.04],0.5124996471305837
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26872,111,1.23 [0.81-1.84],0.3310878991892124
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24806,119,0.89 [0.60-1.33],0.5730196921860662
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25304,617,0.98 [0.82-1.17],0.8185472801245706
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27362,2146,0.97 [0.88-1.07],0.5371365112770204
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24915,228,1.02 [0.76-1.37],0.8763888402949347
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24979,292,1.38 [1.07-1.78],0.0127946089293869
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24839,152,1.09 [0.76-1.56],0.6407017659176959
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27740,36,1.05 [0.51-2.16],0.8910264875298062
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22977,1342,0.93 [0.82-1.04],0.200383017584126
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22048,413,1.24 [1.01-1.54],0.0434165570039539
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28216,403,1.26 [1.02-1.57],0.0324811014228761
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21707,72,1.13 [0.67-1.91],0.6359399072506027
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21986,351,0.97 [0.77-1.22],0.7841306500903142
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25022,335,0.96 [0.76-1.22],0.756753377540546
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22421,786,1.09 [0.93-1.28],0.2725101682985334
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25246,30,1.34 [0.61-2.98],0.4672599433974358
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25782,566,1.14 [0.95-1.37],0.147734442600368
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25503,287,0.98 [0.76-1.27],0.8853498567988863
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22367,732,1.06 [0.90-1.24],0.5001045753668243
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24774,87,1.24 [0.78-1.97],0.3649169347838525
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24751,64,0.79 [0.46-1.37],0.4077602833112748
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26817,56,0.93 [0.52-1.65],0.7990542638403696
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27929,1168,0.99 [0.87-1.13],0.926049382160517
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27422,661,0.92 [0.78-1.10],0.36489248212806
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28161,352,1.05 [0.84-1.33],0.652717246966102
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23447,1812,0.96 [0.87-1.07],0.4690884190844112
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21719,84,1.22 [0.75-1.96],0.4243506250157723
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24769,82,1.58 [0.99-2.53],0.0566349981828155
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21663,28,0.91 [0.39-2.11],0.8253549920834922
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21748,113,0.94 [0.62-1.43],0.7808618156239963
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26996,235,1.19 [0.90-1.58],0.2227340623652773
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27011,250,0.90 [0.68-1.20],0.4801724481815751
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28229,83,1.56 [0.98-2.49],0.0626598709232638
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26820,1604,1.03 [0.93-1.15],0.5443012956168238
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24810,123,1.00 [0.67-1.49],0.9901066388309356
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21753,118,1.19 [0.79-1.77],0.4029472505106778
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25865,649,1.06 [0.89-1.25],0.5389705655597159
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23721,2086,1.07 [0.97-1.18],0.1597506495163012
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27764,60,0.90 [0.51-1.58],0.7060788781469509
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28247,77,0.80 [0.48-1.32],0.3771305619387218
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24771,84,1.40 [0.88-2.23],0.1535164066616673
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25822,1135,1.14 [1.00-1.30],0.0468406016584917
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24757,70,1.22 [0.73-2.05],0.4487605842979204
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22787,1152,1.07 [0.95-1.22],0.2696178225839696
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26865,104,1.09 [0.71-1.67],0.6870858318866089
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24758,71,0.85 [0.50-1.44],0.5387363942434567
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25332,116,1.26 [0.85-1.88],0.2514331752932914
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25103,416,1.26 [1.02-1.56],0.032621100159066
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27917,213,0.81 [0.60-1.10],0.179986513533391
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25690,474,1.21 [0.99-1.47],0.0612898157254323
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28169,332,0.99 [0.78-1.26],0.959053205830018
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28253,38,0.86 [0.42-1.75],0.6708443394081003
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24894,207,0.96 [0.71-1.31],0.8065263967421871
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22686,612,1.18 [0.99-1.40],0.0687841261960092
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25202,515,1.18 [0.98-1.43],0.0838429350247852
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24858,171,0.86 [0.61-1.22],0.3989394843174672
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21670,35,1.42 [0.69-2.93],0.340205577515017
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23456,1821,1.04 [0.94-1.15],0.481269036600092
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22100,465,0.97 [0.79-1.19],0.7517736368720959
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27789,85,0.51 [0.31-0.82],0.0060765384750437
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28197,51,2.14 [1.20-3.80],0.0097218534187857
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26627,29,1.57 [0.74-3.32],0.2412330996024385
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21714,79,0.79 [0.48-1.31],0.3641762167928626
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25309,93,0.77 [0.49-1.21],0.2530707849692858
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21991,356,1.01 [0.80-1.27],0.9262309356203136
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24965,278,1.08 [0.83-1.40],0.5572855363031459
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25435,219,0.94 [0.70-1.27],0.683808648230479
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25326,110,0.62 [0.41-0.95],0.0268276408607175
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23952,48,1.20 [0.65-2.23],0.563880405879124
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28256,41,0.88 [0.44-1.75],0.7169208113620755
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25300,613,1.05 [0.88-1.25],0.615457503143977
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27795,91,1.77 [1.13-2.77],0.0124515574594744
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27161,2474,1.04 [0.95-1.13],0.4065689715172089
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24801,114,0.82 [0.54-1.24],0.3503934003155159
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25582,366,1.04 [0.83-1.30],0.7614760931756442
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26840,190,1.16 [0.85-1.59],0.3475750911957448
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25371,155,0.95 [0.67-1.35],0.7737616019921681
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26298,1082,1.06 [0.93-1.21],0.3928887173311713
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25937,721,1.03 [0.87-1.21],0.7435891876554565
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24734,47,1.46 [0.79-2.70],0.2236387593288766
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27853,149,0.99 [0.69-1.41],0.9569492823234668
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24847,160,0.97 [0.69-1.38],0.884591908547157
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24748,61,0.77 [0.44-1.35],0.3594432529852144
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21673,38,0.85 [0.42-1.74],0.6644341874835089
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27691,886,1.39 [1.21-1.61],6.110602205155196e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11504,76,1.04 [0.63-1.73],0.8777507972560441
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15276,78,1.12 [0.68-1.84],0.6603825928558558
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27962,333,1.39 [1.10-1.76],0.0055071210575793
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27691,62,0.51 [0.29-0.90],0.020550585323417
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27523,718,2.33 [2.01-2.71],1.8921465947287218e-29
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28075,33,5.25 [3.25-8.48],1.1924360440555808e-11
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28087,194,1.21 [0.89-1.65],0.2167435212904601
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,26002,167,1.07 [0.76-1.51],0.6852487469005757
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dialysis,26867,62,8.45 [6.25-11.43],8.015775898548142e-44
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12198,1156,1.03 [0.91-1.18],0.6088576587850495
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15405,207,0.98 [0.72-1.34],0.9116311222074196
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Endometriosis,11569,141,0.86 [0.59-1.25],0.4192827703351586
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11825,397,0.88 [0.70-1.11],0.2792464263433277
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11865,437,1.15 [0.93-1.42],0.1959577977555201
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23848,4393,1.03 [0.96-1.10],0.3786161988281884
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28112,70,2.43 [1.52-3.89],0.0002256361139824
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydrocele,11131,89,0.74 [0.46-1.19],0.2195770856758688
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26720,235,1.45 [1.09-1.92],0.0108059294413587
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11811,769,1.17 [1.00-1.37],0.0470309342202898
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15265,245,0.89 [0.67-1.18],0.4283564072603629
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11148,106,0.91 [0.60-1.40],0.6805556711314171
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Irregular menses,15275,128,0.92 [0.62-1.36],0.6632059567032039
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11732,304,0.91 [0.70-1.17],0.4490211142873579
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25904,69,1.97 [1.18-3.27],0.0089755992176598
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12878,1450,0.92 [0.82-1.03],0.1487778576300103
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11090,48,0.78 [0.42-1.45],0.4299343865344289
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11528,100,1.16 [0.74-1.81],0.523629869133964
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28261,41,1.68 [0.87-3.25],0.1205817505404057
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28266,48,0.61 [0.32-1.16],0.1307139723102894
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27385,1550,1.06 [0.95-1.18],0.3275747954647496
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26321,486,0.98 [0.80-1.20],0.8576466508834603
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15267,69,1.05 [0.62-1.80],0.8502201621248336
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28219,326,1.58 [1.25-2.00],0.0001108700868855
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11197,155,0.85 [0.60-1.22],0.3877805034907751
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11159,117,1.16 [0.77-1.73],0.4743435880999013
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11120,78,0.70 [0.43-1.15],0.158756586035154
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28233,54,1.51 [0.84-2.72],0.167963274988772
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26955,1120,1.09 [0.96-1.25],0.1786876764238925
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15146,126,1.13 [0.77-1.67],0.541022469212511
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11517,89,0.71 [0.44-1.13],0.1498439169121903
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11663,235,1.03 [0.77-1.37],0.8533057141110286
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11488,60,0.89 [0.50-1.59],0.7020054842676835
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11536,108,1.02 [0.67-1.56],0.928138148801168
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26753,268,1.59 [1.22-2.08],0.0005656311011612
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28007,114,1.59 [1.07-2.37],0.0211854568934001
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11611,183,0.79 [0.57-1.11],0.1736997306961397
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11509,81,0.66 [0.40-1.09],0.1074494277242286
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11871,443,0.91 [0.74-1.12],0.3895877422553159
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11497,69,0.74 [0.43-1.26],0.2656514803575145
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11820,392,1.01 [0.81-1.27],0.8959642342872775
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28092,50,2.34 [1.32-4.16],0.003780786786439
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11150,108,1.08 [0.70-1.65],0.7297909579527446
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28063,1578,1.52 [1.37-1.70],1.6886332304295208e-14
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26630,145,1.58 [1.11-2.27],0.0122894162269818
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26885,80,2.38 [1.50-3.77],0.000213830912525
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27701,72,1.74 [1.07-2.84],0.0258545096550527
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26006,171,1.20 [0.86-1.67],0.2866319248186931
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28027,398,1.32 [1.07-1.64],0.0106778487602516
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11534,106,0.98 [0.64-1.52],0.9441953945249808
